Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma

Tumor Biology

Volumn 36, Issue 9, 2015, Pages 6679-6689

  Duan, Hong Fang ^a,b   Li, Xiao Qing ^a,c   Hu, Hong Yi ^a   Li, Yu Chi ^a,c   Cai, Zhi ^a   Mei, Xue Shuang ^a   Yu, Peng ^a   Nie, Li Ping ^a   Zhang, Wei ^d   Yu, Zhen Dong ^a   Nie, Guo Hui ^a  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d Biomedical Research Institute   (China)

Author keywords

CDK16; GALNT7; miR 494; Nasopharyngeal carcinoma; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE; MICRORNA; MICRORNA 494; N ACETYLGALACTOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN494 MICRORNA, HUMAN; PCTAIRE-1 PROTEIN KINASE; UDP-N-ACETYLGALACTOSAMINE--POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CDK16 GENE; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GALNT7 GENE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NASOPHARYNX CARCINOMA; ONCOGENE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; GENETICS; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; N-ACETYLGALACTOSAMINYLTRANSFERASES; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; RNA, MESSENGER;

EID: 84947129155     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3356-8     Document Type: Article

References (38)

1. Yang S, Li Y. MicroRNAs: novel factors in clinical diagnosis and prognosis for nasopharyngeal carcinoma. Acta Pharmacol Sin. 2012;33(8):981–2.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
3. Ma BB, Hui EP, Chan AT. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Cancer Sci. 2008;99:1311–8.
4. Kim Y, Kim B, Jung S, Jung SL, Lee YS, Kim MS, et al. Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea. Cancer Res Treat. 2008;40:155–63.
5. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol. 2005;23(6):1118–24.
6. Ma BB, Chan AT. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer. 2005;103(1):22–31.
7. Zhang ZC, Fu S, Wang F, Wang HY, Zeng YX, Shao JY. Oncogene mutational profile in nasopharyngeal carcinoma. Onco Targets Ther. 2014;7:457–67.
8. Lu R, Ji Z, Li X, Zhai Q, Zhao C, Jiang Z, et al. MiR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J Cancer Res Clin Oncol. 2014;140(3):387–97.
9. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz Jr LA, Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Sci U S A. 2006;103(10):3687–92.
10. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 2004;5(5):396–400.
11. Zhang F, Li Y, Zhou Q. Advances in the relationship between microRNA and cisplatin resistance of lung cancer. Zhongguo Fei Ai Za Zhi. 2014;17(3):269–72.
12. Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–69.
13. Liu N, Jiang N, Guo R, Jiang W, He QM, Xu YF, et al. MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Mol Cancer. 2013;12(1):123.
14. Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, et al. MiR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun. 2010;391(1):535–41.
15. Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS, et al. Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PLoS One. 2014;9(1):e86149.
16. Liu N, Tang LL, Sun Y, Cui RX, Wang HY, Huang BJ, et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett. 2013;329(2):181–8.
17. Zhao JJ, Yang JH, Lin JH, Yao N, Zhu YH, Zheng JL, et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009;25(1):13–20.
18. Olaru AV, Ghiaur G, Yamanaka S, et al. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology. 2011;54(6):2089–98.
19. Ohdaira H, Sekiguchi M, Miyata K, Yoshida K. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif. 2012;45(1):32–8.
20. Kim WK, Park M, Kim YK, Tae YK, Yang HK, Lee JM, et al. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res. 2011;17(24):7584–94.
21. Kwak SY, Yang JS, Kim BY, Bae IH, Han YH. Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B RhoGAP. Biochim Biophys Acta. 2014;1843(3):508–16.
22. Tutar L, Tutar E, Tutar Y. MicroRNAs and cancer; an overview. Curr Pharm Biotechnol. 2014;15(5):430–7.
23. Xing YU, Yibo WU, Yang LI, Deng H, Shen Z, Xiao B, et al. MiR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma. Curr Pharm Biotechnol. 2014;15(5):503–8.
24. Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, et al. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Prostate. 2014;74(7):756–67.
25. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 2006;7(6):599–604.
26. Ten Hagen KG, Fritz TA, Tabak LA. All in the family: the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases. Glycobiology. 2003;13(1):1R–16R.
27. Li W, Ma H, Sun J. MicroRNA34a/c function as tumor suppressors in Hep-2 laryngeal carcinoma cells and may reduce GALNT7 expression. Mol Med Rep. 2014;9(4):1293–8.
28. Peng RQ, Wan HY, Li HF, Liu M, Li X, Tang H. MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7. Biol Chem. 2012;287(17):14301–9.
29. Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, et al. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene. 2011;30(49):4843–54.
30. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, de Vega-Saenz M, et al. MiR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 2011;20(1):104–18.
31. Hua F, Sun J, Guo F, Yin S, Zhang Q, Zhang W, et al. Effect of downregulated histone deacetylase 2 expression on cell proliferation and cell cycle in cervical cancer. J BUON. 2014;19(2):497–501.
32. Hibino S, Saito Y, Muramatsu T, Otani A, Kasai Y, Kimura M, et al. Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis. 2014;3(5):e104.
33. Sladeczek F, Camonis JH, Burnol AF, Le Bouffant F. The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins. Mol Gen Genet. 1997;254(5):571–7.
34. Mokalled MH, Johnson A, Kim Y, Oh J, Olson EN. Myocardin-related transcription factors regulate the Cdk5/Pctaire1 kinase cascade to control neurite outgrowth, neuronal migration and brain development. Development. 2010;137(14):2365–74.
35. Wang Y, Fu J, Jiang MM, Zhang XA, Cheng L, Xu XJ, et al. MiR-410 is over-expressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism. PLoS One. 2014;9(10):e108708.
36. Tang HL, Wang ZY, Liu Q, Liu XP, Wu MH, Li GY. Disturbing miR-182 and miR-381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4. PLoS One. 2014;9(1):e84146.
37. Zhu C, Shao PF, Bao ML, Li P, Zhou H, Cai HZ, et al. MiR-154 inhibits prostate cancer cell proliferation by targeting CCND2. Urol Oncol. 2014;32(1):31. e9-16.
38. Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D, et al. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene. 2012;31(42):4509–16.